https://www.socictopen.socict.org/files/original/ef59aee52ac77724c17bfab5e34037f2.pdf 2136a305a9a93e048af9b8195872ba59 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus disease-19 and rheumatological disorders: A narrative review Creator An entity primarily responsible for making the resource Vikas Sharma, Aman Sharma, GSRSNK Naidu, Arghya Chattopadhyay, Debashish Mishra Description An account of the resource The global spread of coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2, which originated from Wuhan, China, is likely to have an impact on the rheumatological practices due to a dilemma in both continuing and initiating immunosuppressive medications. We reviewed the risk stratification of patients with rheumatological disorders, the safety of various anti-rheumatological drugs, and the role of multiple drugs used by the rheumatologists in managing COVID-19. The score-based risk stratification is helpful in therapeutic decision-making such as self-isolation, continuation, or initiation of immunosuppressive therapy. Most of the immunosuppressive therapies need not be discontinued unless there is an overwhelming infection. The treatment interruption should not be made in fear, and there should be shared decision-making in consultation with the patient. The proposed role of different anti-rheumatic drugs such as hydroxychloroquine and tocilizumab in COVID-19 based on some initial uncontrolled trials and case reports will become clearer when the results of various ongoing well-planned studies become available. Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource Rheumatology, Tocilizumab, hydroxychloroquine, severe acute respiratory syndrome coronavirus, coronavirus disease-19 Identifier An unambiguous reference to the resource within a given context DOI: 10.4103/injr.injr_73_20 Source A related resource from which the described resource is derived Indian Journal of Rheumatology Publisher An entity responsible for making the resource available Wolters Kluwer Medknow Publications Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Diseases of the musculoskeletal system